Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care

Core Viewpoint - Accuray Incorporated and the University of Wisconsin School of Medicine and Public Health have signed a memorandum of understanding (MOU) to collaborate on advancing online adaptive radiotherapy (OART) using Accuray's helical radiation treatment delivery platform, aiming to enhance personalized cancer care [1][2]. Group 1: Collaboration Details - The collaboration will focus on clinical research, education, training, and adaptive technology development to improve the personalization and precision of cancer treatment [1][2]. - Mu Young Lee, SVP of Research & Product Development at Accuray, emphasized the mutual goal of expanding the curative power of radiotherapy and making advanced treatment options feasible for clinical departments of all sizes [2]. Group 2: Technological Background - The University of Wisconsin–Madison developed the first helical radiation delivery platform, the TomoTherapy System, which introduced integrated 3D daily image-guidance with intensity-modulated radiation therapy (IG-IMRT) [3]. - Accuray has continued to enhance the helical platform to improve precision, accuracy, image quality, speed, versatility, and workflow efficiencies since the TomoTherapy System's introduction [3]. Group 3: Institutional Background - The University of Wisconsin School of Medicine and Public Health is recognized as a leading institution in health sciences education and research, employing over 5,600 faculty and staff and providing educational opportunities for nearly 3,000 students [5]. - The school ranked 9 among public medical schools for NIH funding in federal fiscal year 2024, highlighting its strong research capabilities [5].